FindMyKOL
Clinical trialNCT00090779TerminatedPhase 2Interventional

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

SponsorAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsEnrollment130HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Although some doctors favor starting anti-HIV treatment as soon as possible after patients learn they are infected, it is not known if treatment for recently infected patients results in long-term benefits or harm. The purpose of this study is to learn whether or not people should take anti-HIV drugs when they are first infected.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Christine Hogan, MD

    Division of Infectious Diseases, Columbia University College of Physicians and Surgeons

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Peru
  • San Miguel Crs

    San Miguel, Lima region, Peru

  • Asociacion Civil Impacta Salud Y Educacion - Miraf Crs (11301)

    Lima, Peru

United States
  • Ucsd, Avrc Crs (701)

    San Diego, California, United States

  • Ucsf Aids Crs (801)

    San Francisco, California, United States

  • Harbor-Ucla Med. Ctr. Crs (603)

    Torrance, California, United States

  • University of Colorado Hospital Crs (6101)

    Aurora, Colorado, United States

  • University of Miami Aids Crs (901)

    Miami, Florida, United States

  • the Ponce de Leon Center Crs

    Atlanta, Georgia, United States

  • Northwestern University Crs (2701)

    Chicago, Illinois, United States

  • Rush Univ. Med. Ctr. Actg Crs (2702)

    Chicago, Illinois, United States

  • Indiana University Hospital (2601)

    Indianapolis, Indiana, United States

  • Ihv Baltimore Treatment Crs (4651)

    Baltimore, Maryland, United States

  • Brigham and Women'S Hosp. Actg Crs (107)

    Boston, Massachusetts, United States

  • Massachusetts General Hospital Actg Crs (101)

    Boston, Massachusetts, United States

  • Washington University Crs (2101)

    St Louis, Missouri, United States

  • Beth Israel Medical Center

    New York, New York, United States

  • Hiv Prevention & Treatment Crs (30329)

    New York, New York, United States

  • Aids Care Crs (1108)

    Rochester, New York, United States

  • University of Rochester Actg Crs (1101)

    Rochester, New York, United States

  • Unc Aids Crs (3201)

    Chapel Hill, North Carolina, United States

  • Moses H. Cone Memorial Hospital Crs (3203)

    Greensboro, North Carolina, United States

  • Regional Center for Infectious Disease, Wendover Medical Center Crs (3203)

    Greensboro, North Carolina, United States

  • the Ohio State Univ. Aids Crs (2301)

    Columbus, Ohio, United States

  • Hosp. of the Univ. of Pennsylvania Crs (6201)

    Philadelphia, Pennsylvania, United States

  • the Miriam Hosp. Actg Crs (2951)

    Providence, Rhode Island, United States

  • Uw Primary Infection Clinic Crs (1404)

    Seattle, Washington, United States

  • University of Washington Aids Crs (1401)

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2005
Primary completion
31 Jul 2009
Completion
31 May 2011
Last update posted
11 Oct 2018
Registered enrollment
130
Registry id
NCT00090779

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.